Literature DB >> 17301650

Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000.

Tsuyoshi Fujimoto1, Jun Kato, Junichirou Nasu, Motoaki Kuriyama, Hiroyuki Okada, Hiroshi Yamamoto, Motowo Mizuno, Yasushi Shiratori.   

Abstract

BACKGROUND: Although the number of ulcerative colitis patients has increased rapidly in Japan, few reports have been published regarding their clinical aspects. We investigated the clinical characteristics and chronological change of ulcerative colitis in Japanese patients.
METHODS: Patients diagnosed with ulcerative colitis during the period from 1981 to 2000 were registered and their clinical profiles were analyzed. The chronological changes in clinical aspects, such as onset age, sex distribution, severity, extent of disease, clinical course, and corticosteroid use, were also determined.
RESULTS: A total of 844 patients were registered, composed of 431 men and 413 women, with a median onset age of 34 years. The proportion of mild colitis and proctitis was significantly larger in patients with an onset at over 60 years of age, relative to those with an onset at less than 30 years (P<0.016). The proportion of ulcerative colitis patients with old age onset (P=0.09), male sex (P<0.01), mild colitis (P<0.01), proctitis (P<0.01), one-attack-only type (P<0.01), and not-treated-with-corticosteroid (P<0.01) demonstrated a chronological increase from 1981 to 2000.
CONCLUSIONS: The distinctive clinical features and chronological change were seen in Japanese ulcerative colitis patients in recent years. Our data can help understand clinical aspects of ulcerative colitis patients in Asia, where the incidence of ulcerative colitis is still increasing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301650     DOI: 10.1097/MEG.0b013e3280110fb9

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  17 in total

1.  The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis.

Authors:  Jin Ha Lee; Jae Hee Cheon; Eun Soo Kim; Moon Jae Chung; Wonseok Kang; Duk Hwan Kim; You Jung Ha; Jae Jun Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2009-06-09       Impact factor: 3.199

2.  Seasonal variations in the onset of ulcerative colitis in Japan.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Hiroaki Saito; Tetsuji Yokoyama; Tomoyoshi Shibuya; Naoto Sakamoto; Kan Uchiyama; Hiroshi Arakawa; Taro Osada; Akihito Nagahara; Sumio Watanabe; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2013-12-21       Impact factor: 5.742

3.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

Review 4.  Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions.

Authors:  Günter Klöppel; Sönke Detlefsen; Suresh T Chari; Daniel S Longnecker; Giuseppe Zamboni
Journal:  J Gastroenterol       Date:  2010-06-12       Impact factor: 7.527

5.  Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification.

Authors:  Othman R Alharbi; Nahla A Azzam; Ahmed S Almalki; Majid A Almadi; Khalid A Alswat; Nazia Sadaf; Abdulrahman M Aljebreen
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

7.  Survey of inflammatory bowel diseases in India.

Authors:  Govind K Makharia; Balakrishnan S Ramakrishna; Philip Abraham; Gourdas Choudhuri; Sri Prakash Misra; Vineet Ahuja; Shobna J Bhatia; Deepak K Bhasin; Sunil Dadhich; Gopal K Dhali; Devendra C Desai; Uday C Ghoshal; B D Goswami; Sanjeev K Issar; Ajay K Jain; Venkataraman Jayanthi; Goundappa Loganathan; C Ganesh Pai; Amarender S Puri; Surinder S Rana; Gautam Ray; Shivaram P Singh; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2012-10-17

8.  Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: a prospective cohort study.

Authors:  Aki Kawakami; Makoto Tanaka; Masakazu Nishigaki; Makoto Naganuma; Yasushi Iwao; Toshifumi Hibi; Hiromi Sanada; Noriko Yamamoto-Mitani; Keiko Kazuma
Journal:  J Gastroenterol       Date:  2012-12-04       Impact factor: 7.527

9.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis.

Authors:  Yasuo Suzuki; Mamoru Watanabe; Toshiyuki Matsui; Satoshi Motoya; Tadakazu Hisamatsu; Hirotoshi Yuasa; Junichi Tabira; Naoki Isogawa; Shinichi Tsuchiwata; Shoko Arai; Toshifumi Hibi
Journal:  Inflamm Intest Dis       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.